Characterization of a soluble, oligomeric HIV-1 gp160 protein as a potential immunogen
- 1 June 1995
- journal article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 183 (1) , 103-117
- https://doi.org/10.1016/0022-1759(95)00038-c
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Serotyping International HIV-1 Isolates by V3 Peptides and Whole GP160 Proteins Using BIAcoreMethods, 1994
- HIV-1/HIV-2 seronegativity in HIV-1 subtype 0 infected patientsThe Lancet, 1994
- Characterization of Human Immunodeficiency Virus Type 1 Isolates from Children in Romania: Identification of a New Envelope SubtypeThe Journal of Infectious Diseases, 1994
- Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccineThe Lancet, 1993
- A Phase I Evaluation of the Safety and Immunogenicity of Vaccination with Recombinant gp160 in Patients with Early Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991
- HIV-1 Neutralizing Monoclonal Antibodies Induced by a Synthetic PeptideAIDS Research and Human Retroviruses, 1990
- Characterization of the Secreted, Native gp120 and gp160 of the Human Immunodeficiency Virus Type 1AIDS Research and Human Retroviruses, 1990
- Antibodies from Human Immunodeficiency Virus-Infected Individuals Bind to a Short Amino Acid Sequence that Elicits Neutralizing Antibodies in AnimalsAIDS Research and Human Retroviruses, 1989
- Neutralizing monoclonal antibodies to the AIDS virusAIDS, 1988
- Characteristics of a Neutralizing Monoclonal Antibody to the HIV Envelope GlycoproteinAIDS Research and Human Retroviruses, 1988